These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10071725)
1. Antimicroglia antibodies in sera of Alzheimer's disease patients. Lemke MR; Glatzel M; Henneberg AE Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725 [TBL] [Abstract][Full Text] [Related]
2. Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease. McRae A; Dahlström A; Ling EA Gerontology; 1997; 43(1-2):95-108. PubMed ID: 8996832 [TBL] [Abstract][Full Text] [Related]
3. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown. Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711 [TBL] [Abstract][Full Text] [Related]
6. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. Peress NS; Fleit HB; Perillo E; Kuljis R; Pezzullo C J Neuroimmunol; 1993 Oct; 48(1):71-9. PubMed ID: 8227309 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies. Dahlström A; McRae A; Polinsky R; Nee L; Sadasivan B; Ling EA Mol Neurobiol; 1994; 9(1-3):41-54. PubMed ID: 7888106 [TBL] [Abstract][Full Text] [Related]
8. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects. Lopez OL; Rabin BS; Huff FJ; Rezek D; Reinmuth OM Stroke; 1992 Aug; 23(8):1078-83. PubMed ID: 1636181 [TBL] [Abstract][Full Text] [Related]
9. [Alzheimer's disease and the immune system response]. Akiyama H Nihon Rinsho; 1994 Nov; 52(11):2990-4. PubMed ID: 7996699 [TBL] [Abstract][Full Text] [Related]
10. Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. Singh VK; Fudenberg HH Immunol Lett; 1986 Jun; 12(5-6):277-80. PubMed ID: 2942467 [TBL] [Abstract][Full Text] [Related]
11. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease. Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's Disease-like Early-phase Brain Pathogenesis: Self-curing Amelioration of Neurodegeneration from Pro-inflammatory 'Wounding' to Anti-inflammatory 'Healing'. He J; Liao T; Zhong GX; Zhang JD; Chen YP; Wang Q; Zeng QP Curr Alzheimer Res; 2017; 14(10):1123-1135. PubMed ID: 28413987 [TBL] [Abstract][Full Text] [Related]
13. The immune response in the Alzheimer's disease brain. Banati RB Biochem Soc Trans; 1997 May; 25(2):683-5. PubMed ID: 9191182 [No Abstract] [Full Text] [Related]
14. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Mecocci P; Parnetti L; Donato R; Santucci C; Santucci A; Cadini D; Foà E; Cecchetti R; Senin U Brain Behav Immun; 1992 Sep; 6(3):286-92. PubMed ID: 1392102 [TBL] [Abstract][Full Text] [Related]
15. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters. Gruden MA; Davidova TB; Malisauskas M; Sewell RD; Voskresenskaya NI; Wilhelm K; Elistratova EI; Sherstnev VV; Morozova-Roche LA J Neuroimmunol; 2007 May; 186(1-2):181-92. PubMed ID: 17477976 [TBL] [Abstract][Full Text] [Related]
16. Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study. Szpak GM; Lechowicz W; Lewandowska E; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Schmidt-Sidor B; Dymecki J Folia Neuropathol; 2001; 39(3):181-92. PubMed ID: 11770129 [TBL] [Abstract][Full Text] [Related]
17. Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease. Sugiura M; Yokoi Y; Maruyama S; Ishido T; Tokunaga Y; Sasaki K J Clin Lab Immunol; 1989 Jan; 28(1):1-3. PubMed ID: 2657070 [TBL] [Abstract][Full Text] [Related]
18. Anti-brain spectrin immunoreactivity in Alzheimer's disease: degradation of spectrin in an animal model of cholinergic degeneration. Fernández-Shaw C; Marina A; Cazorla P; Valdivieso F; Vázquez J J Neuroimmunol; 1997 Jul; 77(1):91-8. PubMed ID: 9209273 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process. McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756 [TBL] [Abstract][Full Text] [Related]
20. Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias. Schott K; Wormstall H; Dietrich M; Klein R; Batra A Psychiatry Res; 1996 Jan; 59(3):251-4. PubMed ID: 8930031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]